| EPE0958 | Differentiated HIV services for key populations: the new initiatives by NGO in delivery HIV self-testing and other support services in Malaysia via the JOM TEST programme a.k.a JOM TEST 2.0 | E-poster | Integration of HIV services with other health and support services |
| OAA0302 | Differential susceptibility of cells infected with defective and intact proviruses to HIV-selective cell killing by small molecule therapies | Oral abstract session with live Q&A | Understanding and targeting persistent HIV reservoirs |
| OAD0103 | Different forms of violence among displaced and conflict-affected women living with HIV (WLHIV) in Ukraine | Oral abstract session with live Q&A | Sexualities and sexual cultures: Meanings, identities, norms and communities |
| EPB0144 | Differences in time to HCV treatment initiation following HCV diagnosis in the broad direct-acting antiviral era in five countries | E-poster | Co-infections (including opportunistic infections) |
| MOPED16 | Differences between sexual risk behaviours, HIV care utilization, and experience of stigma and violence between cisgender and transgender men who have sex with men: findings from Biobehavioural Surveys in Ukraine | Poster exhibition | Social, political, legal and behavioural determinants of health in different contexts |
| EPD0575 | Development of the HIV Care Continuum & Beyond Initiative: key focus areas to end HIV in the Asia-Pacific region | E-poster | Social and behavioural aspects and approaches to HIV |
| EPA0009 | Development of an efficient method based on Nanopore technology for sequencing of HIV-1 near full-length genomes from plasma | E-poster | HIV virology |
| EPC0329 | Development of a novel HIV genome sequencing assay for routine molecular epidemiology in Australia | E-poster | Surveillance: Measuring the HIV epidemic |
| EPB0112 | Development of a low-cost ART resistance test for Nigeria’s HIV population | E-poster | Diagnostic and monitoring tools |
| EPB0118 | Development of a clinical prediction tool to estimate mortality within one year from antiretroviral therapy initiation in children and adolescents living with HIV to guide differentiated service delivery | E-poster | Diagnostic and monitoring tools |